Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment

• Published in: PloS one Vol. 17; no. 9; p. e0274181
• Main Authors: Satomi Takei, Tomohiko Ai, Takamasa Yamamoto, Gene Igawa, Takayuki Kanno, Minoru Tobiume, Makoto Hiki, Kaori Saito, Abdullah Khasawneh, Mitsuru Wakita, Shigeki Misawa, Takashi Miida, Atsushi Okuzawa, Tadaki Suzuki, Kazuhisa Takahashi, Toshio Naito, Yoko Tabe
• Format: Journal Article
• Language: English
• Published: Public Library of Science (PLoS) 15.09.2022

Quantitative measurement of SARS-CoV-2 neutralizing antibodies is highly expected to evaluate immune status, vaccine response, and antiviral therapy. The Elecsys® Anti-SARS-CoV-2 S (Elecsys® anti-S) was developed to measure anti-SARS-CoV-2 S proteins. We sought to investigate whether Elecsys® anti-S...